PFE vs PUBM · P/E 20, rev $62.58B vs P/E 156, rev $282.9M
Pfizer Inc (PFE) versus Pubmatic Inc (PUBM) — a side-by-side from cached financials, not a winner call.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Pubmatic Inc (PUBM) is a software - application company listed on US.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Latest reported PUBM revenue for 2025-12-31 was $282.9M. Net income was -$14.5M. Revenue was down 2.9% from 2024-12-31 to 2025-12-31. PUBM currently screens at market cap $604.7M and trailing P/E 155.8.
PFE currently screens at market cap $147.73B and trailing P/E 19.8. PUBM currently screens at market cap $604.7M and trailing P/E 155.8.
Not investment advice. Open the PFE and PUBM stock pages for the full models.
Not investment advice.